What You Ought to Know
- Precision oncology and most cancers threat intelligence platform CancerIQ introduced a serious architectural improve to its Epic Systems integrations, introducing a redesigned affected person expertise through Threat Hub and a consolidated supplier utility deployed natively inside Epic workflows.
- Constructed natively on the HL7 FHIR R4 interoperability customary, the supplier integration permits chart-aware threat evaluation that robotically pulls present scientific variables from Epic—together with household most cancers histories, private diagnoses, prior breast biopsies, breast density stories, lab findings, and medicine regimens—to get rid of duplicative affected person information entry.
- Embeds scientific decision-support pointers immediately into Epic to establish affected person eligibility throughout hereditary threat screening, germline and somatic genetic testing, biomarker panels, minimal residual illness (MRD) monitoring, and multi-cancer early detection (MCED) blood assessments with out requiring clinicians to modify home windows or log into exterior third-party portals.
Chart-Conscious Supplier Integration Constructed on FHIR R4
Deployed throughout greater than 60 well being methods and 275 clinic places (reaching roughly 1 in 10 sufferers nationwide), the upgraded integrations are accessible through Connection Hub on the Epic Showroom.
The upgraded supplier integration makes use of the HL7 FHIR R4 customary to bi-directionally learn from and write to Epic, eliminating redundant information entry and maintaining clinicians inside their native EHR interface:
- Prepopulated Chart Ingestion: Robotically ingests present chart information—together with household most cancers histories, private diagnoses, prior biopsies, breast density markers, treatment lists, and previous lab/genomic outcomes—to auto-populate threat evaluation fashions earlier than the clinician opens the chart.
- Embedded Guideline Engine: Evaluates ingested affected person information towards evidence-based scientific pointers to find out eligibility for:
- Hereditary most cancers threat evaluation and genetic testing (e.g., BRCA1/2, Lynch syndrome).
- Focused biomarker testing.
- Well being-system-specific Minimal Residual Illness (MRD) surveillance monitoring.
- Rising Multi-Most cancers Early Detection (MCED) blood-based screening applications.
- Unified In-EHR Workflows: Clinicians can evaluation and refine pedigrees, order indicated genetic/biomarker assessments by customary EHR computerized supplier order entry (CPOE), and generate personalised care plans (screening intervals, imaging modalities, and specialty referrals) immediately inside Epic.
- EHR Genomics Module Synergy: Works alongside specialised digital well being document instruments (resembling Epic’s native Genomics module at accomplice well being methods like OSF HealthCare) to transform advanced genomic variant stories into structured, actionable scientific surveillance schedules.
Redesigned Affected person Expertise through “Threat Hub”
Alongside the clinician toolset, CancerIQ up to date its patient-facing utility, Threat Hub, which could be deployed independently or alongside the EHR supplier module:
- Affected person Portal Integration: Sufferers authenticate securely through their well being system’s affected person portal (e.g., Epic MyChart) and authorize CancerIQ to tug supported EHR well being information.
- Lowered Consumption Burden: As an alternative of filling out clean family-history questionnaires from scratch, sufferers evaluation, affirm, or replace pre-populated data.
- Longitudinal Precision Navigation: Supplies clear, tailor-made threat literacy training explaining why particular genetic assessments or dense-breast MRIs are indicated, whereas guiding sufferers by post-test surveillance intervals and survivorship care plans over time.
“As CancerIQ has expanded to help extra of the affected person journey, bringing these capabilities immediately into Epic was the pure subsequent step,” mentioned Feyi Ayodele, Co-founder and CEO of CancerIQ. “Care groups shouldn’t have to depart Epic to do their greatest work, and sufferers ought to have a transparent understanding of their threat, advisable subsequent steps and what comes after. These updates carry suppliers and sufferers collectively, serving to everybody keep a step forward of most cancers.”
